Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Non-Hodgkin’s Lymphoma

CTech 24/7

  • Laser beams and battlefield proof: Israeli arms firms sell their war story in Paris
  • CTech's War Room: Live Log - June 15, 2025
  • Cyberattacks against Israel surge 700% in two days, says Radware
  • Israel-Iran War: The world responds
More stories in CTech

Non-Hodgkin’s Lymphoma

1 stories about Non-Hodgkin’s Lymphoma
  • Teva's Israeli headquarters. Photo: Bloomberg

    Teva, Celltrion Gain FDA Approval for Generic Blood Cancer Bio-Drug

    29.11.18|Lilach BaumerCalled Truxima, the drug has been approved to treat several conditions of non-Hodgkin’s lymphoma

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive